Development and Migration of Plasma Cells in the Mouse Lymph Node  by Fooksman, David R. et al.
Immunity
ArticleDevelopment and Migration of Plasma Cells
in the Mouse Lymph Node
David R. Fooksman,1,5 Tanja A. Schwickert,2 Gabriel D. Victora,2 Michael L. Dustin,1,* Michel C. Nussenzweig,2,3,*
and Dimitris Skokos2,4,5
1Program in Molecular Pathogenesis and Department of Pathology, Skirball Institute of Biomolecular Medicine,
New York University School of Medicine, New York, NY 10016, USA
2Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10021 USA
3Laboratory of Molecular Immunology, Howard Hughes Medical Institute, The Rockefeller University, New York, NY 10021 USA
4Regeneron Pharmaceuticals, Tarrytown, NY 10591-6707, USA
5These authors contributed equally to this work
*Correspondence: michael.dustin@med.nyu.edu (M.L.D.), nussen@mail.rockefeller.edu (M.C.N.)
DOI 10.1016/j.immuni.2010.06.015SUMMARY
In this study, we imaged the differentiation and
migratory behavior of nascent plasma cells (PCs) in
mouse lymph nodes by intravital microscopy. Pre-
PCs exhibited a unique migration pattern character-
ized by long, linear paths that were randomly
oriented. Although chemotaxis via Gai coupled-
receptors has been implicated in PCmigration, treat-
ment with Pertussis toxin (Ptx), which ablates these
signals, did not prevent movement of pre-PCs while
it arrested other lymphocytes. In vitro, pre-PCs dis-
played processive amoeboid locomotion on surfaces
coated with integrin ligand, whereas fully differenti-
ated PCs moved slowly or were arrested. Both PC
arrest and differentiation occurred in the medullary
cords. Ptx treatment before PC differentiation
blocked their accumulation in the medullary cords
but pre-PCs still differentiated in other lymph node
regions. Taken together, we suggest pre-PCs
undergo a persistent random walk to find the medul-
lary cords, where localized chemokines help retain
these cells until they undergo differentiation and
arrest in situ.
INTRODUCTION
Plasma cells (PCs) play important roles in the acute response to
infection and the long-term protection of the host by acting as
antibody factories (Calame et al., 2003; Tarlinton et al., 2008).
These terminally differentiated B cells can be divided into two
subsets. Short-lived PCs are produced early in the immune
responses, starting on day 3 after immunization; they provide
a first wave of lower-affinity antibodies but die shortly thereafter
(Ho et al., 1986). Meanwhile, long-lived late PCs are produced by
T cell-dependent germinal centers (GCs) that coalesce around
day 6 after immunization and can continue to generate PCs for
weeks. These late PCs generate higher-affinity antibodies
through affinity maturation (Radbruch et al., 2006). Acute abla-
tion of the GC by anti-CD40 treatment halts generation of new118 Immunity 33, 118–127, July 23, 2010 ª2010 Elsevier Inc.PCs and prevents further improvements of antibody affinity
(Takahashi et al., 1998).
PCs are identified by syndecan-1 surface expression, have an
extensive rough endoplasmic reticulum (ER), and are enriched
within the red pulp of the spleen, in the medullary cords of lymph
nodes, and in the bone marrow (Smith et al., 1996). The precur-
sors of PCs (pre-PCs, also called plasmablasts) are dividing cells
that are found in B cell follicles in addition to red pulp andmedul-
lary cords, but not in the bonemarrow. Plasma cells and pre-PCs
are collectively referred to as antibody-secreting cells (ASCs) or
antibody-forming cells (AFCs) on the basis of their ability to
secrete antibody, which is often class-switched.
PC differentiation is dependent on a key transcriptional
repressor, Blimp-1 (Calame et al., 2003), which inhibits many B
cell lineage (Pax5) and GC-specific (Aicda, Bcl6) genes (Shaffer
et al., 2002). By repressing Pax5, Blimp-1 allows expression of
XBP1, a transcription factor essential to survive ER stress asso-
ciated with massive antibody secretion. Kallies et al., (2004) in-
serted a DNA construct consisting of an internal ribosome entry
site followed by a green fluorescent protein (GFP) cDNA into
exon 6 of the Prdm1 locus to generate a Blimp-1 reporter mouse
(Blimp-1-GFP) and showed Blimp-1 expression as an early
marker of PC development. Pre-PCs expressed lower levels of
Blimp-1-GFP than fully differentiated PCs and were heteroge-
neous for syndecan-1 expression (Kabashima et al., 2006;
Kallies et al., 2004).
Within secondary lymphoid organs, both short- and long-lived
PCs localize to medullary cords in lymph nodes and red-pulp
regions of the spleen, where they are thought to secrete antibody
(Smith et al., 1996). Within these anatomic locations, PCs are
largely sessile (Allen et al., 2007; Schwickert et al., 2007). PC
migration to these regions has never been visualized directly,
but chemokine receptors are thought to play a role because
expression of CXCR4, CCR6, and EBI2 increases and CXCR5
is reduced during PC differentiation (Hargreaves et al., 2001;
Pereira et al., 2009; Wehrli et al., 2001). In addition, in vitro trans-
well assays have shown chemotaxis of spleen red pulp PCs to
the chemokines S1p and CXCL12, which are ligands of
S1p1/S1p3 and CXCR4 receptors, respectively (Hargreaves
et al., 2001; Kabashima et al., 2006). Consistent with this idea,
CXCL12 is expressed in red pulp and medullary cords, and
genetic ablation experiments showed that CXCR4-deficient
PCs failed to accumulate in red pulp or bone marrow but were
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CXCR4-sufficent cells (Hargreaves et al., 2001). These results
suggest a role for CXCL12 in PC homing (Hargreaves et al.,
2001; Wehrli et al., 2001).
Long-lived PCs egress from lymph nodes, and homing to the
bone marrow is critical for their long-term survival. In both
s1p1- and b2-integrin-deficient conditions (Kabashima et al.,
2006; Pabst et al., 2005), PCs are unable to exit the lymph nodes.
S1p expression is high in blood and low in secondary lymphoid
organs, providing a gradient that may be used for egress (Rosen
and Goetzl, 2005; Schwab and Cyster, 2007). Intercellular adhe-
sionmolecule-1 (ICAM-1) is highly expressed inmedullary cords,
which are the exit sites of PCs from lymph nodes.
From these reports and others, an image of newly minted pre-
PCs leaving the germinal center to the medullary cords along
a chemokine highway has emerged. However, the current model
of pre-PC chemotaxis to the medullary cords poses a few
conceptual challenges. Although CXCL12 is a candidate for at-
tracting PCs to the medullary cords, it is not clear how pre-
PCs would first escape from the GC, where CXCL12 is also
used to partition GC B cells between the light and dark zones
(Allen et al., 2004). After exit from the GC, a long and stable che-
mokine gradient would have to be produced to attract cells to
structures that may lie millimeters away. Finally, for many exist-
ing paradigms for chemokine function (Allen et al., 2004; Baje´noff
et al., 2006), regions of abundant cognate chemokines often lead
to high cell motility, although in the case of plasma cells, their
localization in the medullary cords seems to correlate with an
arrested phenotype.
We used direct intravital imaging of pre-PCs with two-photon
laser scanning microscopy (TPLSM) to understand their migra-
tion. Surprisingly, pre-PCs exhibit a randomly oriented highly
linear migration within the follicle and T zone that does not
depend on Gai signaling. Processive amoeboid locomotion
with rare direction changes provides an efficient means for
pre-PCs to reach the medulla without a need to evolve a distinct
chemotactic system. Upon reaching the medullary cords, che-
mokine and adhesive contacts may serve to confine and retard
PCs within the medullary cords while they mature and arrest.
RESULTS
Generation and Characterization of Blimp-1YFP Mice
To study plasma cells in vivo, we used bacterial artificial chromo-
some transgenic mice (Rutishauser et al., 2009) that express
yellow fluorescent protein (YFP) cDNA under the control of regu-
latory sequences from the Prdm1 locus (Turner et al., 1994),
which encodes the Blimp-1 protein. These Blimp-1-YFP+ mice
showed normal B cell development in the spleen, bone marrow,
and peritoneum when compared to wild-type B6 mice
(Figure S1A). Consistent with the Blimp-1-GFP reporter mouse
(Kallies et al., 2004), analysis of lymphoid organs showed that
only a small number of B cells (which varied 0.05% to 0.5% in
a given mouse) expressed the Blimp-1-YFP transgene in the
spleen or bone marrow in the steady state, and these cells ex-
pressed syndecan-1+, CD19lo, B220lo, CD43+, CXCR5, and
CXCR4+ surface profiles consistent with plasma cells (Figures
S1B and S1C available online). As reported by others (Kallies
et al., 2004), some ASCs were syndecan-1+Blimp-1-YFP(Figure S1B), possibly because of transgene variegation effects
(Williams et al., 2008).
To examine the development of antigen-specific plasma cells
in vivo, we produced Blimp-1YFP mice that also carry the B1.8hi
immunoglobulin (Ig) heavy-chain allele (Blimp-1-YFP+-B1.8hi
mice), which encodes a nitrophenyl (NP) hapten-specific B cell
receptor when combined with Igl (Shih et al., 2002). Naive
(CD45.2+Blimp-1-YFP+B1.8hi) B cells were adoptively trans-
ferred into congenic (CD45.1+) B6 recipients, boosted with NP-
OVA or without (control), and analyzed for short- or long-lived
PC production at early (day 4) or late (day 10) times, respectively,
as well as an in-between (day 7) time point during the response.
Transferred B cells produced a small subset of YFP+ cells that
accumulated in draining lymph nodes, peaking at day 7
(Figure 1A). Although both YFPhi and YFPlo populations were
detectable at all three time points, the YFPhi cells increased after
day 4. On day 7, within the GC compartment of the transferred
population (2% of total), a rare fraction (0.09%) of YFP+ cells
could be detected (Figure 1B), which were YFPlo cells. Trans-
ferred B cells were subdivided into naive, GC, YFPhi, and YFPlo
populations and analyzed for surface phenotypes (Figure 1C).
The YFPhi cells were consistent with a PC surface phenotype,
namely syndecan-1+CD19loCXCR5lo, whereas half of YFPlo cells
were syndecan-1+. These surface phenotypes for the character-
ized subsets were consistent with analyses on day 10. On day 4,
YFPhi cells showed no CD19 downregulation (Figure 1C), consis-
tent with a short-lived plasma cell phenotype (Kallies et al.,
2004). Heterogeneous expression of syndecan-1 by the Blimp-
1-YFPlo cells is consistent with these cells containing transitional
pre-PCs (Kallies et al., 2004).
To characterize nascent pre-PCs, we sorted Blimp-1-YFP+-
Fas+GL7+ cells and compared their cellular structures to sorted
populations of naive, GC B cells, and PCs by using transmission
electron microscopy. The cellular morphology of the pre-PCwas
more consistent with GC cells than mature PCs (Figure 1D),
although they showed some expansion in their ER, consistent
with early stages of plasma cell differentiation (Geuze and Slot,
1980).
Blimp-1-YFP+ Distribution in the Lymph Node
We characterized PC development during an immune response
by determining the distribution and expression of Blimp-1-YFP+
cells within the lymph node. Using TPLSM on days 4, 7 and 10,
we obtained 3D-tiled stacks from both the follicular and medul-
lary sides of fixed popliteal lymph nodes, which represented
50%–75% of the total lymph node volume. We identified Blimp-
1-YFP+B1.8hi (green) distribution within the medullary cords
(cyan, labeling various macrophages by nonspecific uptake of
quantum dots), follicular dendritic cell (FDC) network of the GCs
(red labeling byNP-Tomato surface adhesion), and the remaining
B cell follicles and T cell zone, collectively called BT zones. We
found Blimp-1-YFP+ cells concentrated in the medulla but
present throughout the BT zones as well, with a few cells within
GCs on days 7 and 10 (Figures 2A and 2B). In contrast, naive B
cells (blue), expressing cyan fluorescent protein (CFP) constitu-
tively, were more commonly distributed within B cell follicles
than in the medulla. The few rare Blimp-1-YFP+ cells found in
GCs appeared to be positioned along the periphery of the struc-
ture (MovieS1, FigureS2).Wecomparedpre-PCdistributionwithImmunity 33, 118–127, July 23, 2010 ª2010 Elsevier Inc. 119
Figure 1. Characterization of Blimp-1-YFP+ Cells
Purified, naive B1.8hiBlimp-1-YFP+ B cells were transferred into immunized congenic CD45.1+C57BL/6 recipients. Mice were boosted subcutaneously with
NP-OVA or without (control) 1 day after transfer. Lymphocytes were analyzed 4, 7, and 10 days after boost by flow cytometry. Numbers reflect the relative
percentages of cells within the gates.
(A) Transferred cells (CD45.1) generated rare Blimp-YFP+ cells on days 4, 7, and 10 but not in control mice.
(B) Day 7 transferred cells were subdivided into YFPhi, YFPlo, and YFP populations, and the GC compartment (Fas+GL7+) was assessed. Some YFPlo cells were
GC+ but none were YFPhi.
(C) Transferred populationswere subdivided into naive B cells (gate I: YFPFasGL7), GCB cells (gate II: YFPFas+GL7+), YFPlo (gate III), and YFPhi (gate IV) and
analyzed for surface expression of CD19, CD138, CXCR4, and CXCR5. For comparison, CD19 and CD138 profiles are shown for day 4 and day 10 populations.
Flow-cytometry analysis shows samples pooled from duplicate mice in a single experiment, but is representative of at least three independent experiments.
(D) Naive (B220+), GC (Fas+/GL7+), plasma cell (B220+, syndecan-1+), and pre-PC (Blimp-1-YFP+, Fas+/GL7+) B cells were all sorted (98% purity) and imaged by
transmission electron microscopy.
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peripherally localized than naive B cells. In a previous study in
which Blimp-1 expression was identified in the GC, there was120 Immunity 33, 118–127, July 23, 2010 ª2010 Elsevier Inc.no mention of a peripheral localization (Angelin-Duclos et al.,
2000). However, differences in the techniques from these two
studies could account for the discrepancy.
Figure 2. Blimp-1-YFP+ Distribution in the Lymph Node
Recipient mice were prepared for imaging as in Figure 1 to induce B1.8hiBlimp-
1-YFP+ cells in vivo (green). Before imaging, mice received IV transfers of naive
CFP+ B cells (blue) as controls and subcutaneous injection of QDot705
(that label phagocytes concentrated in the medullary cords, in cyan) plus
NP-tomato (to label FDCs in NP-specific GC light zones in red). (A) Examples
of flattened 3D stacks taken by TPLSM of the follicle and medulla sides of
whole fixed popliteal lymph nodes from days 4, 7, and 10 are shown. Auto-
mated analysis of the images was used to determine Blimp-1-YFP cell distri-
butions within medullary cords, GCs, and other regions (collectively referred
to as BT zones) per lymph node and summarized in (B) as percent total. The
same analysis was made for naive CFP B cells for comparison. At least four
lymph nodes were pooled per condition. Error bars represent standard error
of the mean (SEM). Scale bars represent 200 mm in all images.
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We imaged the migratory behavior of Blimp-1-YFP+ cells in the
lymph node by intravital time-lapse TPLSM. In vivo, Blimp-1-
YFP+ cells in the follicle were similar in size and shape to blasting
GC B cells, which are larger and more polarized than naive B
cells (Schwickert et al., 2007) (Movie S2). In general, Blimp-1-
YFP+ were highly motile in the follicle and largely sessile in the
medullary cords (Figure 3A). Blimp-1-YFP+ cell migration
seemed to be similar on days 4, 7, and 10 (Movie S2, Figure 3B),
with cells in the medullary cords slightly more motile on day 4
than on days 7 or 10, which correlated with their transition frompre-PC to PC in the medulla. Outside the medullary cords,
Blimp-1-YFP+ cell average track velocity was lower than naive
cells (Figure 3B) although some cells reached similar speeds.
Pre-PC migration was highly linear over long distances and
less confined as compared with naive B cells, which migrate
randomly in the follicle. To determine whether pre-PCs were
more processive than naive B cells, we calculated the average
mean squared displacement (MSD) for cell tracks over time. As
modeled in Figure 3C, the MSD for random walk scales linearly
with time, whereas the MSD for confined motion reached
a plateau. Random walks with long free-path lengths or persis-
tent random walks generate exponential MSD plots that accel-
erate with increased path lengths (see Codling et al., 2008;
Zygourakis, 1996 for further discussion). We calculated the
MSD for Blimp-1-YFP+ cells, segmented by day and region,
and compared them to control naive B cells in those fields. The
MSD plots for naive cells had initial slopes that were linear and
reached a maximum displacement after 30 min consistent
with limited follicle size (Figure 3D). Nonmedullary Blimp-1-
YFP+ cells showed higher displacements than naive B cells,
despite having slower speeds (Figure 3B). Based on fitting the
average MSD plots to an equation for 3D persistent random
walk (see Experimental Procedures), pre-PCs showed an
average 3 min persistence time, compared to 1 min for naive
cells. Confinement of Blimp-1-YFP+ cells in the medullary cords
increased at later time points (Figure 3D).
Despite a high degree of linearity in pre-PC movement, anal-
ysis of the track displacement showed no overall directionality
at any time point (Figure 3E). We could not detect a bias in
pre-PC displacements along any axis, or when compared to
naive B cells in the same fields. In movies that contained regions
of medulla or GC, pre-PCs showed no bias toward or away from
these elements (Movies S2). Moreover, we anecdotally observed
Blimp-1-YFP+ pre-PCs crawling linearly until reaching the
capsule of the lymph node, changing direction, and continuing
in a new direction, in what appeared to be a blind search for
the medulla (Movie S3).
In Vivo Requirements for Blimp-1+ Pre-PC Migration
Despite the absence of directional movement by pre-PCs,
changes in CXCR4 and CXCR5 chemokine receptor expression
on PCs and reports of chemotaxis in vitro suggested that
chemokinesis might have a role in coordinating pre-PC motility
in the lymph node (Hargreaves et al., 2001; Wehrli et al., 2001).
To determine whether G protein-coupled receptor (GPCR)
signaling might be involved in pre-PC motility in vivo, we treated
mice with a high dose of Pertussis toxin (Ptx), which ablates Gai
signaling and most chemokine-directed movement (Kaslow
and Burns, 1992) in B cells. Treatment with Ptx completely
stopped naive B cell migration (Figure 4B), which served as
a positive control; cells extended small filopodial projections
(Movies S4 and S5) but were completely confined based on their
MSD plots (Figure 4C). In contrast, most Blimp-1-YFP+ cells
continued crawling and in a highly linear fashion based on the
MSD plots (Figure 4D), but with reduced average track velocity
(4.8 to 3.9 mm/s2, Figure 4B). One explanation for this small
reduction may be the presence of large numbers of arrested
lymphocytes creating barriers and added resistance to Blimp-1
cell migration. We saw similar trends in migration at all threeImmunity 33, 118–127, July 23, 2010 ª2010 Elsevier Inc. 121
Figure 3. Dynamics of Blimp-1-YFP+ Cell Migra-
tion
Imaging conditions as described in Figure 2 were used to
image Blimp-1-YFP migration at days 4, 7, and 10.
(A) Images of movies with sample cell tracks that were
segmented by region asmedullary cords (red) or BT zones
(yellow) on various days. Sample tracks from naive B cells
(blue) are in gray. Scale bars represent 110 mm.
(B) Average track velocities from populations from several
imaging experiments, from various days, segmented by
region and pooled, were tallied and plotted with t tests
comparing regions with p values abbreviated as
** (p < 0.001) and *** (p < 0.0001).
(C) Hypothetical plots of the MSD over time for a random
Brownian walk, a confined migration, and a random walk
with persistence (or flowmigration) as reference for exper-
imental measurements.
(D) MSD plots from the populations in (B) for naive B cells
(black), Blimp-1-YFP+ cells within BT zones (green), or
medullary cords (red) from all three time points. Error
bars represent SEM.
(E) The x,y,z displacements from Blimp-1-YFP+ (green)
and naive B cell (blue) tracks are plotted for three sample
movies from each time point. Means and standard devia-
tion (SD) are marked. t tests were performed between
naive and Blimp-1+ components for each movie, but
none reached a 95% significance.
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that were already arrested remained arrested. We confirmed
that Blimp-1-YFP+ cells were capable of chemotaxis in response
to CXCL12, as had been previously reported for pre-PCs. Both
Blimp-1-YFP+ cells and naive cells migrated toward CXCL12 in
an in vitro transwell migration assay (Figure S3A). Pretreatment
of these cells with Ptx completely blocked transwell migration.
S1p chemokine signaling has also been implicated in PC
chemotaxis and migration from the medulla to the bone marrow.
S1p signals through S1p1 and S1p3 GPCRs, which use the Ptx-
sensitive Gai for signaling. However, S1p3 can also utilize the
Ptx-insensitive Ga12,13 and Gaq for signaling (Spiegel and122 Immunity 33, 118–127, July 23, 2010 ª2010 Elsevier Inc.Milstien, 2003). To block these additional path-
ways, we also gave Ptx-treated mice FTY720,
which downregulates S1p1 and S1p3 receptors
and prevents signaling. Mice treated with both
Ptx and FTY720 showed no significant differ-
ences in pre-PC movement when compared to
mice treated with Ptx (Figure S3B). These
experiments indicate that although Blimp-1+
cells are capable of (in vitro) chemotaxis, their
migration in vivo is only partially dependent on
chemokine cues.
Pre-PC Migration Is Adhesion Mediated
We conducted in vitro live-cell imaging studies
to determine what factors mitigate Blimp-1-
YFP+ cell motility to allow arrest in the medulla.
Glass substrates were coated with the adhesion
molecule ICAM-1 and with or without chemo-
kine ligands CXCL12 or CXCL13. We focused
on ICAM-1 because of the established roleof b2 integrins in PC egress from lymph nodes and the presence
of high levels of ICAM-1 on many lymph node cells (Pabst et al.,
2005). In vitro-activated Blimp-1-YFP+ cells were imaged in
combination with naive dsRed+ B cells as controls. We used
interference reflection microscopy (IRM) to image the cell con-
tacting the substrate in order to measure adhesion and differen-
tiate crawling versus fluid flow movement. Both cell types were
capable of migrating on these substrates (Figure 5A, Movies
S6 and S7). Naive cells migrated rapidly in response to either
chemokine but also on ICAM-1 alone if BSA was present
(Figure 5C), and chemokines were required for naive cell
migration in the presence of fatty-acid-free BSA (Figure S5).
Figure 4. Ptx Blocks Migration of Naive B Cells but
Not pre-PC Migration
Blimp-1-YFP+ and naive B cells were imaged on days 4, 7,
and 10 as described in Figure 3. Mice were treated or not
with Ptx 1 day prior to imaging.
(A) Sample images from 3D time-lapse movies on days 4,
7, and 10 from Ptx-treated mice (see Figure 3 legend).
Scale bars represent 110 mm.
(B) Quantification of average track velocity for naive cells
and for Blimp-1-YFP+ cells on days 4, 7, and 10,
segmented by regions. t tests were performed between
conditions. ***p < 0.001.
(C) MSD plots comparing conditions in (B) with (red) or
without (black) Ptx treatment. Error bars represent SEM.
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and also reduced their ability to adhere to the substrate
(Figure 5E). In contrast, Blimp-1-YFP+ cells, which migrated
slower than naive cells (Figure 5C), only required ICAM-1 for
migration (Figure S5). Blimp-1-YFP+ cell adhesion and migration
on ICAM-1 substrates were unaffected by Ptx (Figures 5B, 5D,
and 5E, Movie S8).
Based on the IRM image captured during cell migration, we
could visualize the cell footprint, which informs on the binding
to ICAM-1, as well as the mode of locomotion. Blimp-1+ cells,
which are larger cells, had a larger contact surface than naive
B cells, even when normalized to the cell size (Figures 5F and
5G). In time-lapse movies, we observed that (Movie S9) naive
B cells had a dynamic and transient IRM image, with frequent
rounds of detachment and reattachment to the substrate.
In contrast, Blimp-1+ cells showed a stable IRM pattern, which
spread evenly as they migrated in a processive amoeboid
fashion.Immunity 33Blimp-1+ cell velocity was heterogeneous
in vitro (Figure 5C) and in vivo (Figure 3B).
However, the cell speed was inversely related
to YFP+ expression, a measure of their matura-
tion state (Kallies et al., 2004). YFPlo cells were
highly motile, whereas YFPhi cells appeared
slow or arrested (Figure 6A). This relationship
was also detected in in vivo track analysis
(Figure 6B). Because this behavior is seen on
ICAM-1 alone, it suggests PC arrest is cell
autonomous.
Proper PC Localization in Medulla
Requires Chemokine
On day 4 after immunization, large numbers of
early pre-PCs develop and migrate, with
80% accumulation in the medullary cords as
compared to 10% of naive B cells. However,
Ptx treatment (24 hr before visualization)
reduced PC accumulation in the medulla to
40% while leaving naive B cells distributed nor-
mally (Figures 7A and 7B, Movie S5). BT zones
normally contain YFPlo cells consistent with
pre-PC; however, after treatment, BT zones
were enriched in YFPhi cells consistent withPCs (Figure 7C). At later time points, most PCs were already ar-
rested in themedullary cords, and Ptx treatment had no effect on
their distribution (data not shown). We conclude that chemokine
signaling is required for Blimp-1+ cell accumulation in the
medulla.
DISCUSSION
PC retention in secondary lymphoid organs and bone marrow is
critical for their long-term survival. Using a newly generated
Blimp-1-YFP mouse, we were able to image pre-PCs as they
differentiate and migrate to become PCs. To understand their
migration, we compared their behavior to naive B cells, which
are found throughout the lymph node. Naive B cells migrate
rapidly in the B cell follicle in random directions, with short linear
excursions punctuated by frequent turns (Miller et al., 2002). This
frequent random turning is thought to be mediated by chemo-
kine signals, particularly CXCL13, presented on surfaces of, 118–127, July 23, 2010 ª2010 Elsevier Inc. 123
Figure 5. Migration of Blimp-1+ Cells Is Adhesion
Mediated
(A and B) Examples of in vitro time-lapse movies of
ICAM-1 coated slides with Blimp-YFP+ cells (green) and
naive B cells (red) that were pretreated with Ptx (B, Movie
S8) or not (A, Movie S7). Tracks are overlaid, with colors
respective to the cell type.
Naive and Blimp-1+ cell migration was plotted as average
track velocity (C) or displacement velocity (D). Ptx-treated
naive cells showed decreases in migration (D) and adhe-
sion (E) to the substrate, as compared to Blimp-1+ cells.
(F) Examples of IRM contact area of naive and Blimp-1+
B cells compared to their cell body (or fluorescent) area
(see Movie S9).
The ratio of IRM area to cell area was computed (G) for
both cell populations, and the two means were different
(p = 0.004).
Bars represent mean ± SD error. Scale bars represent
70 mm.
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between turns is set by the spacing of natural branch points in
the stromal network (Baje´noff et al., 2006; Okada and Cyster,
2006). The exploration of this elaborate stromal network allows
for a high-density search inside the B cell follicle (Miller et al.,
2002). Consistent with the proposed role of chemokines in naive
B cell movement in lymph nodes, Ptx treatment caused them to
arrest.
In vivo, pre-PCs displayed a greater displacement velocity
than naive B cells, and their pattern of migration was similar to
a random walk but with a very long free-path length between
turns. We describe this as a ‘‘random sprint.’’ Pre-PCs showed
no directional bias away from the GC or follicle or toward the
medullary cords, as might be expected for chemotaxis. This
is consistent with the minor effect on migration by blocking che-
mokine signals with Ptx and FTY720 treatment. The pre-PCs
only appear to turn when they encounter obstacles like the
subcapsular sinus (Movie S4), suggesting that their migration
to themedulla may be stochastic. The long, linear paths followed
by pre-PC are shared by positively selected thymocytes moving
toward the thymic medulla (Witt et al., 2005). However, the
movement of the positively selected thymocytes is highly
directed and chemotactic, whereas this is not the case for the
movement of pre-PCs. Because the motility coefficient for a124 Immunity 33, 118–127, July 23, 2010 ª2010 Elsevier Inc.random walk process scales linearly with
the free-path length or time persistence
(Zygourakis, 1996), random motility with a long
free path is an ideal strategy to search for the
medullary cords, a compartment that may be
hundreds of microns from the GC (Friedrich,
2008).
In vitro migration of naive and Blimp-1 cells
revealed a more mechanistic explanation for
the in vivo observations. Naive B cell contacts
with the ICAM-1 surface were highly dynamic
and rapidly contracted. Their migration and
even adhesion to ICAM-1 was Ptx sensitive,
suggesting a requirement for Gai signaling. In
contrast, Blimp-1+ cells adhered to ICAM-1and displayed slow and steady migration in the presence of
Ptx and the absence of chemokine signals. Both of these two
modes of migration have recently been described for naive
T cells by Jacobelli et al., (2009). T cells can migrate either with
an intermittent amoeboid locomotion dependent upon myosin
IIa contraction or with a processive amoeboid ‘‘sliding’’ mode
involving continuous ICAM-1 adhesion linked to retrograde actin
flow. Naive B cells primarily use the intermittent, low adhesion
mode allowing for frequent direction changes, whereas pre-
PCs use the processive adhesion-dependent mode, leading to
persistence of direction over tens of microns. This search
strategy is effective because the long free-path length is well
matched to the distances that the pre-PCs need to travel to
reach the medullary cords. Pre-PCs may use FRC and FDC
branched networks as scaffolds for adhesion and migration.
However, their long free paths suggest that pre-PCs do not
utilize these networks exclusively. ICAM-1 is probably not the
only adhesion molecule that pre-PCs can use for migration
in lymph nodes. In the absence of b2 integrins, PCs still accumu-
late in the medullary cords but are unable to exit the tissue for
the bone marrow (Pabst et al., 2005). We would propose that
the ICAM-1-dependent arrest of PC allowed maturation in the
medullary cords prior to a slower, integrin-dependent egress
process that allows trafficking to the bone marrow.
Figure 6. Blimp-1+ Cells Arrest with Differentiation
Blimp-1+ cell track velocity on ICAM-1 was plotted as a function of YFP
intensity (A). Analysis of in vivo tracks taken on day 7 showed a similar relation-
ship (B).
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Pre-Plasma Cell Migration in the Lymph NodeThe random sprint serves pre-PCs by facilitating their rapid
exit from the GC. Pre-PCs might encounter a number of
compartments on these random sprints including subcapsular
region, T cell zone, other follicles, cortical sinusoids, and the
medullary cords. Movement between compartments in tissues
has typically been guided by chemokine gradients with CCR7
for T cell zones and thymocyte movement to the medulla
(Nitta et al., 2008), CXCR5 for the follicle, and S1p for the lymph
and blood. Although CXCR4 has a role in accumulation of PC in
the medullary cords, this does not appear to be the product of
chemotaxis and may play additional roles in bone marrow
homing (Hauser et al., 2002).
As pre-PCs mature, their motility arrests in vivo as well as
in vitro.We can observe this phenomenon on ICAM-1 alone, indi-
cating that no extrinsic cues are required, aside from maturation
signals. These Blimp-1-YFPhi cells correspond to arrested
plasma cells in the lymph node. Indeed, Blimp-1-YFPhi cells
are also less chemotactic than Blimp-1-YFPlo cells in transwell
assays with S1p or CXCL12 (Kabashima et al., 2006; Wehrli
et al., 2001). PC arrest and differentiation are coordinated in
the medullary cords through a Ptx-sensitive pathway, but at
short distances. In previous reports, CXCR4/ ASCs were
able to exit white pulp and were more abundant in the bloodthan in the red pulp, consistent with a retention defect rather
than a failure to migrate. Furthermore, inhibition of S1p affected
bone marrow homing but showed normal ASC distribution in the
spleen (Kabashima et al., 2006). Chemotaxis of ASCs to CXCL12
and S1p in in vitro transwell assays may be modeling the in vivo
retention of these cells in the medulla and red pulp rather than
their directed migration to these regions. Indeed, Ptx treatment
inhibited accumulation but not migration to the medulla, sug-
gesting that retention in the medullary cords is chemokine
dependent. PC arrest and differentiation were mislocalized but
not inhibited by Ptx, confirming that in vivo, these processes
are also cell autonomous. Myeloid cells in the medullary cords
may provide survival signals such as BAFF and April (Belnoue
et al., 2008; Mohr et al., 2009) but only for PCs that manage to
find the medullary cords before they arrest. Further work is
needed to determine whether cell-cell interactions contribute
to PC migration and arrest as well.
EXPERIMENTAL PROCEDURES
Animals, Immunization, and Transfer
For adoptive-transfer experiments, wild-type C57BL/6, B6.SJL (CD45.1+),
CFP+, and dsRed+ mice (Jackson Laboratories) 7–12 weeks of age were
used with protocols approved by the Institutional Animal Care and Use
Committee. CD45.1+ hosts were immunized with an intrapertioneal (IP) immu-
nization of 50 mg/mouse of OVA (Sigma) emulsified in Alum (Pierce) to enrich
T cell help 2 weeks prior to cell transfer. B1.8hiBlimp-1-YFP mice (with or
without CFP+ transgene) were used for donor cells. Splenic naive B cells
were purified by CD43 depletion with MACS beads (Miltenyi Biotec) and trans-
ferred intravenously (IV) to hosts (5–10 x 106/mouse). After 24 hr, hosts
received a subcutaneous (S/C) boost in the footpads with 100 mg of NP(15)-
OVA (Biosearch). Lymphocytes were harvested and analyzed 4 to 10 days
later by flow cytometry on a LSR II (BD Bioscences).
For imaging experiments, hosts were imaged on days 4, 7, and 10 after
boost with NP-OVA. One day prior to imaging, naive control B cells purified
from CFP+ B6 mice were adoptively transferred into the mouse recipient as
motility controls. For the labeling of medullary cord macrophages, 1 pmole
of QTracker 705 nontargeted quantum dot (Invitrogen) was injected in the
hind footpad. In addition, 2.5 mg of NP(11)-Tomato or NP-Phycoerythrin (PE)
(Biosearch) was injected in the hind footpad to label the light zone of the GC
structures. NP-tomato was made in house, as a tomato-GST construct,
expressed in e coli, purified by Glutathione column (Amersham), and conju-
gated with NP-SE (Biosearch). For in vivo experiments, Pertussis toxin
(Ptx, 400 mg/kg Calbiochem) was administered IV, and FTY720 (1 mg/kg)
was delivered IP 12–24 hr prior to imaging (Huang et al., 2007).
In Vitro Imaging and Transwell
Blimp-1-YFP+ naive B cells were purified and stimulated with LPS (25 ng/mL),
IL-4 (5 ng/mL), IL-5 (15 ng/mL), and BAFF (10 ng/mL) for 3–4 days. Naive
dsRed+ B cells were purified and incubated in RPMI+10% FBS overnight
before imaging or transwell experiments. For transwell experiments, cells
were incubated in the upper chamber of 5 mm Costar transwells for 2 hr with
CXCL12 (1 mg/mL, R&D Systems) and were counted on a FACScalibur. For
imaging, cells were imaged in Lab-Tek chamber slide systems (Nunc) with
an adapted protocol kindly provided by the laboratory of Ronen Alon at the
Weizmann Institute of Science (Rehovot, IL). Chemokines were spotted on
clean glass surface for 2 hr at 37C, washed, and then spotted with 5 ml of
transmembrane ICAM-1 at 400 molecules/mm2 for 1 hr at room temperature.
The glass surface was blocked with 10% bovine serum albumin (BSA) or
10% fatty-acid-free (FAF)-BSA for 1 hr, washed, and then used for imaging.
Prior to imaging, cells were incubated in RPMI+1% BSA (Regular or FAF,
Sigma) with or without Ptx (50 ng/ml) for 2 hr. Cells were resuspended in
HBSS supplemented with 10 mM HEPES, 2 mg/ml BSA (FAF or Regular),
and imaged at 37C with a Zeiss LSM710 and standard confocal settings for
YFP and dsRed fluorophores.Immunity 33, 118–127, July 23, 2010 ª2010 Elsevier Inc. 125
Figure 7. Ptx Blocks PC Accumulation in Medul-
lary Cords but not Blimp-1+ Expression
(A) As in Figure 2, TPLSM 3D tiled stacks from the follicle
and medulla sides of whole fixed popliteal lymph nodes
from day 4with or without Ptx treatment. Scale bars repre-
sent 200 mm.
(B) The distribution of Blimp-1-YFP and naive B cells was
isolated and segmented into medullary cords, GCs, and
other regions (collectively referred to as BT zones) and
plotted as the total YFP distribution per lymph node (using
both sides of the lymph node). At least four lymph nodes
were pooled per condition. Error bars represent SEM.
(C) The average YFP intensity for all Blimp-1-YFP cells
collected was calculated and plotted by region and Ptx
condition. t test comparisons of the conditions were
made with p values labeled above or with *** (p < 0.001).
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Pre-Plasma Cell Migration in the Lymph NodeTPLSM Imaging and Analysis
For the preparation of imaging, mice were anesthetized with KXA (Ketamine,
Xyalzine, Acepromazine) solution (4 ml/g). We exposed the popliteal lymph
node by shaving the leg and dissecting the skin and fatpad in an aseptic
manner. A metal stabilization plate and coverslip were used to immobilize
the lymph node. The mouse was comforted with regular injections of KXA,
temperature control stage, and nose cone with O2 supplement.
For intravital TPLSM, an upright BioRad microscope was used as before
(Schwickert et al., 2007) with a 403 Nikon objective and also repeated on
a Zeiss LSM-710 inverted microscope with Mai-Tai Sapphire Laser for two-
photon excitation with a 253 objective. Time lapse Z stacks were taken at
30 s intervals on either system, with similar measurements for cell speeds
and migratory behavior. Tiled 3D stacks of the lymph node were collected
on the Zeiss system.
Collected imaging series were analyzed for cell position and dynamics with
Volocity 4.2 (Improvision), Excel 2003 (Microsoft), and GraphPad 4.0 (Prism).
Movies were annotated with Adobe Affect Effects. Cell migrations were
tracked automatically with Volocity, annotated for region, and pruned manu-
ally. Only continuous tracks that persisted at least 6 min in the field were
used for analysis. For cell distributions within a lymph node, cell bodies were
identified by RGB thresholding to cells. Rather than segmenting and counting
individual cells, which were tightly packed particularly in the medullary cords,
we determined the volume (in pixels) corresponding to a cell population, sub-
divided it by region in the lymph node, and presented it as a percentage of the
total volume of the cell population found in the lymph node. Both sides of the
lymph node were totaled for each measurement and repeated for four to six
lymph nodes per condition. For MSD measurements, sampling was rounded
to the nearest minute. The initial 30min of theMSDplots were fit to a 3D persis-
tent random walk (Equation 1) as described (Zygourakis, 1996) via nonlinear
least-squares (Origin 7.0) and solved for persistence time (P) with the average
constant speed from Figure 3B used as speed (S):
MSDðtÞ = 3S2Pt  P21 et=P: (1)126 Immunity 33, 118–127, July 23, 2010 ª2010 Elsevier Inc.Cell Staining and Flow Cytometry
Flow-cytometry measurements were conducted on a BD
LSR II and analyzed with FlowJo 7.2. Cell populations
were stained with BD Pharmagen antibodies unless other-
wise stated: CD19, B220, CD138, CXCR5, CXCR4, Fas,
GL7, and CD45.1.
Electron Microscopy Preparation and Imaging
Cells were washed with serum-free media or appropriate
buffer and then fixed with a modified Karmovsky’s fix of
2.5% glutaraldehyde, 4% paraformaldehyde, and 0.02%
picric acid in 0.1M sodium caocdylate buffer at pH 7.2.
Following a secondary fixation in 1% osmium tetroxide,
1.5% potassium ferricyanide, samples were dehydratedthrough a graded ethanol series, cleared with acetonitrile, and then infiltrated
and embedded in an epon analog resin. Ultrathin sections were cut with a Dia-
tome diamond knife (Diatome) on a Leica Ultracut S ultramicrotome (Leica).
Sections were collected on copper grids, further contrasted with lead citrate,
and viewed on a JSM 100 CX-II electronmicroscope (JEOL) operated at 80 kV.
Images were recorded on Kodak 4489 Electron Image film and then digitized
on an Epson Expression1600 Pro scanner.SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and nine movies and can be
found with this article online at doi:10.1016/j.immuni.2010.06.015.
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